AbstractAimsTo compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer.Materials and methodsA Royal College of Radiologists’ audit of patients treated with radiotherapy in UK cancer centres in 2001–2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary.ResultsData were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemora...
Purpose: Radiotherapy is the standard treatment for locally advanced cervical cancer, but treatment ...
Objective. The aim of this study is to investigate the impact of treatment policy changes in cervica...
PURPOSE: The local failure rate in patients with locoregionally advanced cervical cancer is 41-72% a...
AbstractAimsTo compare survival and late complications between patients treated with chemoradiothera...
BackgroundAfter a 1999 National Cancer Institute (NCI) clinical alert was issued, chemoradiotherapy ...
Background After a 1999 National Cancer Institute (NCI) clinical alert was issued, chemoradiotherapy...
<div><p>Radiotherapy is the standard treatment for cervical cancer, but causes radiotherapy-induced ...
Background: Throughout world over 500000 new cases of invasive cancer cervix are detected each year ...
Expedience of conventional radiotherapy in locally advanced cervix cancer: A retrospective analysis ...
Aim: To report the outcome of carcinoma cervix patients treated radically by external beam radiother...
WOS: 000182102800022PubMed ID: 12701977Purpose: Radiotherapy is the standard treatment for locally a...
Between August 1990 and January 1992, 184 patients with squamous cell carcinoma of the cervix, FIGO ...
Background: Incidence and mortality estimates are used to measure the burden of cancer in a populati...
Abstract Background Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally adv...
Purpose: To report response rate, pelvic tumor control, survival, and late toxicity after treatment ...
Purpose: Radiotherapy is the standard treatment for locally advanced cervical cancer, but treatment ...
Objective. The aim of this study is to investigate the impact of treatment policy changes in cervica...
PURPOSE: The local failure rate in patients with locoregionally advanced cervical cancer is 41-72% a...
AbstractAimsTo compare survival and late complications between patients treated with chemoradiothera...
BackgroundAfter a 1999 National Cancer Institute (NCI) clinical alert was issued, chemoradiotherapy ...
Background After a 1999 National Cancer Institute (NCI) clinical alert was issued, chemoradiotherapy...
<div><p>Radiotherapy is the standard treatment for cervical cancer, but causes radiotherapy-induced ...
Background: Throughout world over 500000 new cases of invasive cancer cervix are detected each year ...
Expedience of conventional radiotherapy in locally advanced cervix cancer: A retrospective analysis ...
Aim: To report the outcome of carcinoma cervix patients treated radically by external beam radiother...
WOS: 000182102800022PubMed ID: 12701977Purpose: Radiotherapy is the standard treatment for locally a...
Between August 1990 and January 1992, 184 patients with squamous cell carcinoma of the cervix, FIGO ...
Background: Incidence and mortality estimates are used to measure the burden of cancer in a populati...
Abstract Background Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally adv...
Purpose: To report response rate, pelvic tumor control, survival, and late toxicity after treatment ...
Purpose: Radiotherapy is the standard treatment for locally advanced cervical cancer, but treatment ...
Objective. The aim of this study is to investigate the impact of treatment policy changes in cervica...
PURPOSE: The local failure rate in patients with locoregionally advanced cervical cancer is 41-72% a...